Nuvalent Inc. Class A Common Stock
NUVLUnited States
20 filed reports · 221 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
20 reports · Jun 2021 to Mar 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 15 | 1,438 | Jun 2021 to Mar 2026 |
| Annual · 10-KSEC EDGAR | 5 | 1,233 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 219 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 487 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 30, 2025 | 160 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 132 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 95 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 27, 2025 | 215 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 12, 2024 | 98 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 79 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 9, 2024 | 83 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 27, 2024 | 126 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 14, 2023 | 81 | Open |
| FY2023 Q2 | 10-Q | Jun 30, 2023 | Aug 10, 2023 | 65 | Open |
Financial data
221 concepts · 2,671 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial220 concepts · 2,623 facts · Mar 2020 to Mar 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value31 · Mar 2020 to Mar 2026
- Net income loss31 · Mar 2020 to Mar 2026
- Stockholders equity (US GAAP)31 · Mar 2020 to Mar 2026
- Allocated share based compensation expense30 · Jun 2020 to Mar 2026
- General and administrative expense (US GAAP)30 · Jun 2020 to Mar 2026
- Nonoperating income expense30 · Jun 2020 to Mar 2026
- Operating expenses (US GAAP)30 · Jun 2020 to Mar 2026
- Operating income loss30 · Jun 2020 to Mar 2026
- Research and development expense30 · Jun 2020 to Mar 2026
- Cash and cash equivalents at carrying value29 · Jun 2020 to Mar 2026
- Comprehensive income net of tax29 · Sep 2020 to Mar 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis liability transfers net29 · Sep 2020 to Mar 2026
- Increase decrease in accounts payable29 · Sep 2020 to Mar 2026
- Increase decrease in prepaid deferred expense and other assets29 · Sep 2020 to Mar 2026
- Net cash provided by used in financing activities29 · Sep 2020 to Mar 2026
- Net cash provided by used in operating activities29 · Sep 2020 to Mar 2026
- Profit loss29 · Sep 2020 to Mar 2026
- Share based compensation29 · Sep 2020 to Mar 2026
- Cash cash equivalents restricted cash and restricted cash equivalents28 · Dec 2020 to Mar 2026
- Accounts payable current27 · Dec 2020 to Mar 2026
- Accrued liabilities and other liabilities27 · Dec 2020 to Mar 2026
- Additional paid in capital common stock27 · Dec 2020 to Mar 2026
- Assets27 · Dec 2020 to Mar 2026
- Assets current27 · Dec 2020 to Mar 2026
Product1 concepts · 48 facts · Dec 2023 to Mar 2026
- Zidesamtinib48 · Dec 2023 to Mar 2026
Segments
48 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service4 members · 48 facts
- Discovery Programs12 · Dec 2023 to Mar 2026
- Neladalkib12 · Dec 2023 to Mar 2026
- NVL-33012 · Dec 2023 to Mar 2026
- Zidesamtinib12 · Dec 2023 to Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary83 claims from 8 reports · Sep 2024 to Mar 2026
- Management discussion (MD&A) commentary136 claims from 7 reports · Sep 2024 to Mar 2026
- Risk-factor changes28 claims from 1 reports · Dec 2025
- Risk factors182 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.